Cargando…

Potential molecular mechanisms of Ermiao san in the treatment of hyperuricemia and gout based on network pharmacology with molecular docking

A network pharmacology integrated molecular docking strategy was used to predict the underlying molecular mechanism of Ermiao san in the treatment of hyperuricemia and gout. Traditional Chinese medicine systems pharmacology (TCMSP) database and analysis platform were used to screen out the active co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Yin-Hong, Yan, Jia-Hui, Han, Liang, Chen, Zhe, Tu, Sheng-Hao, Zhang, Lin-Qi, Song, Chun-Dong, Duan, Feng-Yang, Liu, Ya-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478232/ https://www.ncbi.nlm.nih.gov/pubmed/36123941 http://dx.doi.org/10.1097/MD.0000000000030525

Ejemplares similares

Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology
por: Liu, Pei, et al.
Publicado: (2020)

Pharmacological effects of Chatuphalatika in hyperuricemia of gout
por: Sato, Vilasinee Hirunpanich, et al.
Publicado: (2018)

An Integrative Pharmacology Model for Decoding the Underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid Arthritis
por: Wu, Jie, et al.
Publicado: (2022)

Corrigendum: An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritis
por: Wu, Jie, et al.
Publicado: (2023)

Elucidation of Potential Targets of San-Miao-San in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking Analysis
por: Chu, Man, et al.
Publicado: (2022)

The combination of molecular docking and network pharmacology reveals the molecular mechanism of Danggui Niantong decoction in treating gout
por: Liu, Yuan, et al.
Publicado: (2022)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Molecular Elucidation of a Urate Oxidase from Deinococcus radiodurans for Hyperuricemia and Gout Therapy
por: Chiu, Yi-Chih, et al.
Publicado: (2021)

Study on the mechanism of Wumei San in treating piglet diarrhea using network pharmacology and molecular docking
por: Yin, Huihui, et al.
Publicado: (2023)

Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022)

Improved effect of fresh ginseng paste (radix ginseng-ziziphus jujube) on hyperuricemia based on network pharmacology and molecular docking
por: Zhang, Hao, et al.
Publicado: (2022)

The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking
por: Peng, Xin, et al.
Publicado: (2022)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

An update on the genetic architecture of hyperuricemia and gout
por: Merriman, Tony R
Publicado: (2015)

The role of the Mediterranean diet in hyperuricemia and gout
por: Stamostergiou, Julie, et al.
Publicado: (2018)

Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout
por: Huang, Chung-Ming, et al.
Publicado: (2022)

Research into the mechanism of intervention of SanQi in endometriosis based on network pharmacology and molecular docking technology
por: Lin, Zhiheng, et al.
Publicado: (2022)

Network Pharmacology Integrated with Transcriptomics Analysis Reveals Ermiao Wan Alleviates Atopic Dermatitis via Suppressing MAPK and Activating the EGFR/AKT Signaling
por: Xia, Ting, et al.
Publicado: (2022)

A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia
por: Qian, Yue, et al.
Publicado: (2023)

The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
por: Fang, Xin-yu, et al.
Publicado: (2022)

In Silico Analysis of Pyeongwi-San Involved in Inflammatory Bowel Disease Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics
por: Bae, Chang-Hwan, et al.
Publicado: (2023)

A concise history of gout and hyperuricemia and their treatment
por: Nuki, George, et al.
Publicado: (2006)

Atypical musculoskeletal manifestations of gout in hyperuricemia patients
por: Sakti, Muhammad, et al.
Publicado: (2019)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
por: Pérez-Ruiz, Fernando, et al.
Publicado: (2019)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
por: Cao, Ling, et al.
Publicado: (2021)

Why Does Hyperuricemia Not Necessarily Induce Gout?
por: Zhang, Wei-Zheng
Publicado: (2021)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

Mechanism of Datura metel on sinus bradycardia based on network pharmacology and molecular docking
por: Yang, Feifei, et al.
Publicado: (2022)

Gout, not hyperuricemia alone, impairs left ventricular diastolic function
por: Lin, Jing-Chi, et al.
Publicado: (2015)

Jiawei Foshou San Induces Apoptosis in Ectopic Endometrium Based on Systems Pharmacology, Molecular Docking, and Experimental Evidence
por: Wei, Jiahui, et al.
Publicado: (2019)

Network Pharmacology and Molecular Docking Verify the Mechanism of Qinshi Simiao San in Treating Chronic Prostatitis in the Rat Model
por: Li, Chenxi, et al.
Publicado: (2022)

Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis
por: Fan, Wei, et al.
Publicado: (2023)

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
por: Yi, Pengji, et al.
Publicado: (2020)

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
por: Liu, Jiaqin, et al.
Publicado: (2021)

Febuxostat in the management of hyperuricemia and chronic gout: a review
por: Hu, Miao, et al.
Publicado: (2008)

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010)

Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
por: Bisht, Manisha, et al.
Publicado: (2011)

Circulating microRNA alternations in primary hyperuricemia and gout
por: Bohatá, Jana, et al.
Publicado: (2021)

Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
por: Zhang, Di
Publicado: (2022)

Associations of metal exposure with hyperuricemia and gout in general adults
por: Xu, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pabna5sj2kuqp613o4tsh6vj8r